Moritz J Przybilla

PhD Student @sangerinstitute, former student @UniHeidelberg, Ex-iGEMer @iGEMHeidelberg - interested in #somaticEvolution and #riskprediction.

[Moritz J Przybilla @PrzybillaMoritz]

June really appears to be my lucky month - our new preprint is out on @researchsquare! 😍 Together with @doctor_msc, @andrewrjlawson and many others we looked into the life history of mitochondria in the human haematopoietic system https://t.co/7qjyALrJ65. [1/x]

[Inigo Martincorena @imartincorena]

Excited to share our latest work. We introduce an improved version of NanoSeq, a duplex sequencing protocol with <5 errors per billion bp in single DNA molecules, and use it to study the somatic mutation landscape of oral epithelium in >1000 people. 1/n https://t.co/KBjrDfrxlj

[Moritz J Przybilla @PrzybillaMoritz]

Peter’s departure from Sanger certainly took me by surprise, but I’m equally excited for his next chapter. A wonderful tribute by @imartincorena to someone who I, in my brief experience in this field, consider a true pioneer and even greater human. Academia will miss him dearly.

[Inigo Martincorena @imartincorena]

Peter Campbell leaves the Sanger Institute at the end of the year to become Quotient's CSO. A mentor and one of my favourite scientists. His foundational, profound and creative contributions to cancer genomics and somatic evolution have truly shaped those fields. [1/7]

[Moritz J Przybilla @PrzybillaMoritz]

@khanaziz84 @KaspKarl Didn’t know you were here either! Kasper and I are meeting tomorrow morning at 10 if you have time?! 🙏🏼

[Moritz J Przybilla @PrzybillaMoritz]

If you are at #AACR24 and want to hear work surrounding early carcinogenesis in #lungcancer or risk prediction and prevention in #BreastCancer come and visit me at my posters on Tuesday & Wednesday! All details are in the comments 😊

[Moritz J Przybilla @PrzybillaMoritz]

April 10, 2024, 9:00 AM - 12:30 PM - Abstract 7292 for my project on breast cancer risk prediction:

https://t.co/SaTmutNzZA

[Moritz J Przybilla @PrzybillaMoritz]

April 9, 2024, 1:30 PM - 5:00 PM - Abstract 5657 for the lung carcinogenesis work:

https://t.co/i5RBq699kF

[Moritz J Przybilla @PrzybillaMoritz]

April 10, 2024, 9:00 AM - 12:30 PM - Abstract 7292 for breast cancer risk prediction.

https://t.co/SaTmutNzZA

[Moritz J Przybilla @PrzybillaMoritz]

April 9, 2024, 1:30 PM - 5:00 PM - Abstract 5657 for the lung carcinogenesis.

https://t.co/i5RBq699kF

[Moritz J Przybilla @PrzybillaMoritz]

@bloodgenes @Nature @chenweng1991 @JswLab @broadinstitute @DFBC_PedCare @GRO_Broad @WhiteheadInst @BostonChildrens @DanaFarber @nyscf @HHMINEWS Looks amazing, cannot wait to give the Supplementary Note a read! Congratulations! 😊

[Jannat Ijaz @sciencejannat]

Very excited to share that our work reconstructing chromothripsis has now been published in @CellGenomics! We reconstructed chromosomes with up to 800 rearrangements on a single allele and queried epigenetic and transcriptomic consequences. Thread below!

https://t.co/LWzYFYPPPV

[Thomas Vanderstichele @TVanderstichele]

Excited to share the first preprint of my PhD @sangerinstitute looking into the prevalence and genetic mechanisms of gene misexpression in 4,568 whole blood RNA-seq samples from the INTERVAL cohort. https://t.co/5Ia0Z1YVPR

[Mike Spencer Chapman @doctor_msc]

Gene therapy is big news! https://t.co/XhEOegAjCs
and a major advance for patients with sickle cell disease (SCD) & thalassemia.

But in some recent trials, a small number of patients developed blood cancer. Our study (out in @NatureMedicine ) asked why...
https://t.co/pos7Eqiurn

[Karsten Rippe @KarstenRippe]

Glad to see that the joint study of our team from @HDMyeloma and @DKFZ on how tumor heterogeneity drives therapy resistance in multiple #myeloma is now out in Blood https://t.co/tbNpd0l7X6 and highlighted by @uniklinik_hd https://t.co/SLvOe2YojM

[Monika Krzak @KrzakMonikaS]

So excited to share our work with @Tobioinformatic and @Lelandtlr where we used #singlecell on a large #IBD and healthy cohort to identify gastrointestinal cell types, genes and pathways associated with #Crohns disease !
https://t.co/4TG4vq6p7n

[Elias R. Ruiz-Morales @Elias_RuizMor]

@sangerinstitute PhD students are true DNA enthusiasts, pondering the wonders of genomics anytime, anywhere. Here's a glimpse of our PhD retreat 2023 🧬 #PhDLife #DNA

[Moritz J Przybilla @PrzybillaMoritz]

Great effort by a lot of people including @OliverStegle @KarstenRippe @Simontuk and many others @DKFZ! Most importantly Alex & Nina (both do not seem to have Twitter) who managed to bring this project to completion (at least the first stage). Looking forward to whats ahead!

[Moritz J Przybilla @PrzybillaMoritz]

Concluding a scientifically fantastic June 2023, I am happy to share that our work on therapy resistance in multiple myeloma has been published in @BloodJournal! 🥳 If you are interested in multi-omics analysis of single-cell data, give it a read!

https://t.co/36yGuge5ON

[Moritz J Przybilla @PrzybillaMoritz]

I will end with a fantastic last piece of the paper and some more room for thoughts..peace out ✌️[20/x]

[Moritz J Przybilla @PrzybillaMoritz]

June really appears to be my lucky month - our new preprint is out on @researchsquare! 😍 Together with @doctor_msc, @andrewrjlawson and many others we looked into the life history of mitochondria in the human haematopoietic system https://t.co/7qjyALrJ65. [1/x]

[Moritz J Przybilla @PrzybillaMoritz]

This was only possible due to the great help of many others - in particular @andrewrjlawson, @imartincorena, @Emily_LMitchell, @_Luke_MRH_ as well as @jyoti_nangalia and more (which I probably did not find on twitter - sorry)! [19/x]